The American Association of Clinical Endocrinologists (AACE) is exploring the reportedly high incidences of diabetic ketoacidosis (DKA) in people taking SGLT2 inhibitors. The investigation will take place at a conference the autumn.
SGLT2 inhibitor type 2 diabetes drugs could cause diabetic ketoacidosis
Posted in Drugs Medical Research